darunavir

FDA Drug Profile — Darunavir 600 and 800 mg, PREZISTA

darunavir is listed in the FDA National Drug Code directory with 8 NDC codes, marketed under brand names including Darunavir 600 and 800 mg, PREZISTA. Available dosage forms: tablet, suspension, tablet, film coated.

Drug details

Generic Name
darunavir
Brand Names
Darunavir 600 and 800 mg, PREZISTA
Application Number
ANDA206288
Sponsor
Cipla USA Inc.
NDC Codes
8
Dosage Forms
TABLET, SUSPENSION, TABLET, FILM COATED
Routes
ORAL
Active Ingredients
DARUNAVIR HYDRATE, DARUNAVIR ETHANOLATE, DARUNAVIR DIHYDRATE

Indications and Usage

1 INDICATIONS AND USAGE Darunavir tablets, co-administered with ritonavir (darunavir/ritonavir), in combination with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (HIV-1) infection in adult and pediatric patients 3 years of age and older [see Use in Specific Populations (8.4) and Clinical Studies (14)] . Darunavir tablets are a human immunodeficiency virus (HIV-1) protease inhibitor indicated for the treatment of HIV-1 infection in adult and pediatric patients 3 years of age and older. Darunavir tablets must be co-administered with ritonavir (darunavir/ritonavir) and with other antiretroviral agents. ( 1 )

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.